Back to Journals » Drug Design, Development and Therapy » Volume 9

Combination of erlotinib and a PARP inhibitor inhibits growth of A2780 tumor xenografts due to increased autophagy

Total article views   HTML views PDF downloads Totals
19,700 Dovepress* 18,076+ 2,029 20,105
PubMed Central* 1,624 640 2,264
Totals 19,700 2,669 22,369
*Since 22 June 2015
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
6 0 0 0 2 4

View citations on PubMed Central and Google Scholar